Recurrent and persistent hematuria with focal and segmental glomerular lesions
ICD-10 N02.1 is a billable code used to indicate a diagnosis of recurrent and persistent hematuria with focal and segmental glomerular lesions.
N02.1 refers to a condition characterized by recurrent and persistent hematuria, which is the presence of blood in the urine, associated with focal and segmental glomerular lesions. This condition often indicates underlying glomerular disease, such as glomerulonephritis or nephritis, where inflammation and damage to the glomeruli lead to proteinuria (excess protein in urine) and hematuria. Patients may present with symptoms such as edema, hypertension, and renal impairment. A renal biopsy is typically performed to confirm the diagnosis and assess the extent of glomerular damage. Management may include corticosteroids, immunosuppressants, and supportive care, depending on the underlying cause and severity of the lesions. Regular monitoring of renal function and urine analysis is essential to evaluate disease progression and treatment efficacy.
Detailed clinical notes on hematuria episodes, renal function tests, and biopsy results.
Patients presenting with unexplained hematuria, proteinuria, or renal impairment.
Ensure that all relevant laboratory results and imaging studies are included in the documentation.
Comprehensive pathology reports detailing glomerular lesions and any associated findings.
Biopsy specimens from patients with suspected glomerular disease.
Pathology reports should clearly indicate the type of lesions and their clinical significance.
When a renal biopsy is performed to assess the cause of hematuria and glomerular lesions.
Biopsy report must detail the findings and correlate with clinical symptoms.
Nephrologists should ensure that the biopsy is justified based on clinical indications.
Focal and segmental glomerular lesions indicate localized damage to the glomeruli, which can lead to significant renal impairment and are often associated with specific types of glomerular diseases.